![CARBIDOPA AND LEVODOPA - carbidopa and levodopa tablet - Prescription (RX) Marketed Drugs Encyclopedia CARBIDOPA AND LEVODOPA - carbidopa and levodopa tablet - Prescription (RX) Marketed Drugs Encyclopedia](https://www.drugsdb.eu/images/carbidopa_and_levodopa_3dd640f2-c597-44df-b42c-d61324b4772a-04.jpg)
CARBIDOPA AND LEVODOPA - carbidopa and levodopa tablet - Prescription (RX) Marketed Drugs Encyclopedia
![Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa- levodopa for advanced Parkinson's disease - Journal of the Neurological Sciences Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa- levodopa for advanced Parkinson's disease - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/04781e78-4570-44aa-b140-131f83d20b20/gr1.jpg)
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa- levodopa for advanced Parkinson's disease - Journal of the Neurological Sciences
![PDF) Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off PDF) Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off](https://i1.rgstatic.net/publication/281622406_Efficacy_and_safety_of_entacapone_in_levodopacarbidopa_versus_levodopabenserazide_treated_Parkinson's_disease_patients_with_wearing-off/links/56564cc408ae4988a7b387ce/largepreview.png)
PDF) Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off
![Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study - The Lancet Neurology Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ed8897aa-e310-4604-af70-c4f90b64192c/gr1.gif)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study - The Lancet Neurology
![The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12325-021-01747-1/MediaObjects/12325_2021_1747_Figa_HTML.png)